Gemfibrozil in late preterm and term neonates with moderate jaundice: A randomized controlled trial

Indian Pediatrics

Volumn 46, Issue 12, 2009, Pages 1063-1069

  Jaikrishan, Praveen Kumar ^a   Narang, Anil ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Fibric acid; Gemfibrozil; Jaundice; Neonate; Phototherapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BILIRUBIN GLUCURONIDE; GEMFIBROZIL; PLACEBO;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; INDIA; MALE; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RASH; REPEATED DRUG DOSE; TREATMENT DURATION;

BILIRUBIN; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; GEMFIBROZIL; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; LOGISTIC MODELS; PHOTOTHERAPY; TREATMENT OUTCOME;

EID: 73249138534     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kemper K, Forsyth b, McCarthy P. Jaundice, terminating breast-feeding, and the vulnerable child. Pediatrics 1989; 84: 773-778.
2. Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics 1985; 75: 417-421.
3. Lindenbaum A, Hernandorena, Vial M, Benattar C, Jauand JC, Dehan M, et al. Clofibrate for the treatment of hyperbilirubinemia in neonates born at term: a double blind controlled study. Arch Fr Pediatr 1981; 38: 867-873.
4. Lindenbaum A, Delaporte B, Benattar C, Dehan M, Magny JF, Gerbet D, et al. Preventive treatment of jaundice in premature newborn infants with clofibrate. Double-blind controlled therapeutic trial. Arch Fr Pediatr 1985; 42: 759-763.
5. Nesfield SR, Williams TC, Hoivik DJ, Miller RT, Allen JS, Selinger K, et al. Evaluation of the carcinogenic potential of clofibrate in the neonatal mouse. Int J Toxicol 2005; 24: 341-348.
6. Barbier O, Villeneuve L, Bocher V, Fontaine C, Torra IP, Duhem C, et al. The UDPglucuronosyltransferase 1A9 enzyme is a peroxisome proliferators-activated receptor alpha and gamma target gene. J Biol Chem 2003; 278: 13975-13983.
7. Barbier O, Duran-Sandoval D, Pineda-Torra I, Kosykh V, Fruchart JC, Staels B. Peroxisome proliferators-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme. J Biol Chem 2003; 278: 32852-32860.
8. Xu S, Zhu BT, Turan V, Rusyn I, Thurman R, Peters JM, et al. PPARalpha-dependent induction of liver microsomal esterification of estradiol and testosterone by a prototypical peroxisome proliferator. Endocrinology 2001; 142: 3554-3557.
9. Buyukcelik M, Anarat A, Bayazit AK, Noyan A, Ozel A, Anarat R, et al. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome. Turk J Pediatr 2002; 44: 40-44.
10. Kamin D, Hedigan C. Hyperlipidemia in children with HIV infection: an emerging problem. Expert Rev Cardiovasc Ther 2003; 1: 143-150.
11. Cockington RA. A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia. J Pediatr 1979; 95: 281-285.
12. Research Randomizer: Free random sampling and random assignment. Available from: URL: http:// www.randomizer.org. Accessed on December 15, 2004.
13. Foliot A, Drocourt JL, Etienne JP, Housset E, Fiessinger JN, Christoforov B. Increase in the hepatic glucuronidation and clearance of bilirubin in clofibrate rats. Biochem Pharmacol 1977; 26: 547-549.
14. Mohammadzadeh A, Farhat ASh, Iranpour R. Effect of clofibrate in jaundiced term newborns. Indian J Pediatr 2005; 72: 123-126.
15. Karthikeyan G, Narang A, Majumdar S, Shivani K. Photooxidant injury to glucose-6-phosphate dehydrogenase-deficient erythrocytes with bilirubin as the sensitizer-an in vitro study. Acta Paediatr 1997; 86: 321-322.
16. Tan KL, Boey KW. Efficacy of phototherapy in neonatal hyperbilirubinaemia associated with glucose-6-phosphate dehydrogenase deficient status. Eur J Pediatr 1993; 152: 601-604
17. Jemnitz K, Veres Z, Monostory K, Vereczkey L. Glucuronidation of thyroxine in primary monolayer cultures of rat hepatocytes: In vitro induction of UDP-glucuronosyltranferases by methylcholanthrene, clofibrate, and dexamethasone alone and in combination. Drug Metab Dispos 2000; 28: 34-37.
18. Mounie J, Champion L, Goudonnet H, Escousse A, Truchot RC. Inductive effects of fenofibrate and metabolism of phenobarbital. Fundam Clin Pharmacol 1988; 2: 259-265.
19. Viollon-Abadie C, Bigot-Lasserre D, Nicod L, Carmichael N, Richert L. Effects of model inducers on thyroxine UDP-glucuronosyl-transferase activity. Toxicol Vitro 2000; 14: 505-512.